Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New proton pump inhibitors from Apotex

Nov. 6, 1997

Lexipafant as adjunct for severe acute pancreatitis

Oct. 31, 1997

Roussel Morishita reports antiulcer agents with a novel mechanism of action

Oct. 31, 1997

AD-8717: a novel proton pump inhibitor in the pipeline at Dainippon

Oct. 30, 1997

Muscarinic receptor antagonists claimed by Pfizer for IBS, Alzheimer's disease

Oct. 30, 1997

Genome Therapeutics reaches milestone in H. pylori collaboration

Oct. 30, 1997

FDA clears generic cimetidine

Oct. 29, 1997

Hepatitis C-related technology available for licensing from NIH

Oct. 29, 1997

Shionogi presents potent and selective CCKB/gastrin receptor antagonist

Oct. 29, 1997

Cangene to manufacture new formulation of NABI's H-BIG

Oct. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...